ZVRA
NASDAQ · Pharmaceuticals
Zevra Therapeutics Inc
$11.68
-0.20 (-1.68%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
-54.3% upside
Low Target
$3.67
Average Target
$5.34
High Target
$6.76
Current Price
$11.68
Current
$11.68
$11.68
Target
$5.34
$5.34
$3.67
$5.34 avg
$6.76
Scenario Analysis
Bear Case
$3.67
-68.6%
Low target
Base Case
$5.34
-54.3%
Avg target
Bull Case
$6.76
+-42.1%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$15.04
-22.3% from high
52-Week Low
$7.16
+63.1% from low
Target vs 52W High
$5.34
-64.5% vs high
Next Earnings Report
Aug 10, 2026
1d
tomorrow
EPS Est: $0.11
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals